pudexacianinium chloride for Kidney Failure

"According to the study's admission standards, participants must be between 18 and 75 years old. There are 56 studies available for minors while older patients have access to 523 trials."

"Affirmative. As documented on clinicaltrials.gov, this trial is presently recruiting patients who are willing to partake in the study. The initial posting was made on August 25th 2022 and it has been updated as recently as November 14th 2022. 36 individuals will be accepted across 3 sites for participation."

"Our team at Power has assigned pudexacianinium chloride a score of 1 due to the fact that this medication is currently in its first trial phase, indicating limited evidence exists for both efficacy and safety."

"Yes, this experiment is presently recruiting. According to clinicaltrials.gov, the trial was launched on August 25th 2022 and most recently modified on November 14th of that same year. It requires 36 participants from 3 medical facilities for completion."

"This clinical trial seeks 36 individuals with a healthy BMI range of 17.6 to 30 kg/m^2 and weighing at least 50 kilograms (for male participants) or 40 kilograms (for female). In particular, Women Of Childbearing Potential must agree to contraceptive methods while the study is in progress and for 30 days after its conclusion; additionally, they may not donate ova during this period. Meanwhile, men are prohibited from donating sperm throughout the treatment and post-treatment phases as well as engaging in sexual activities that could result in pregnancy with their partner(s), who must also use contraception over these timespans. Moreover, all candidates"

"This trial's primary objective is to quantify the absorption, distribution, metabolism and excretion (PK) of ASP5354 in urine over a duration of up to three days. Secondary goals include assessing any adverse events related to participant vital signs, laboratory values or electrocardiograms."